|Table of Contents|

Incidence and mortality of female breast cancer in Heilongjiang Province in 2017 and its changing trend in 2013-2017

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 09
Page:
1736-1740
Research Field:
Publishing date:

Info

Title:
Incidence and mortality of female breast cancer in Heilongjiang Province in 2017 and its changing trend in 2013-2017
Author(s):
JIA Haihan1; SUN Huixin2; WANG Wanying1; ZHANG Maoxiang2; SONG Bingbing2
1.Heilongjiang Cancer Center，Harbin Medical University Cancer Hospital，Heilongjiang Harbin 150081，China;2.Heilongjiang Cancer Center，Harbin Medical University Institute of Cancer Prevention and Treatment，Heilongjiang Harbin 150081，China.
Keywords:
breast cancer; incidence; mortality; Heilongjiang Province
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2023.09.029
Abstract:
Objective:To analyze the incidence and mortality of female breast cancer in the tumor registration area of Heilongjiang Province in 2017 and discuss the changing trend from 2013 to 2017.Methods:To collect breast cancer incidence，mortality and population data reported from 12 tumor registration areas in Heilongjiang Province.To calculate the morbidity，mortality，age-standardized rate of China，age-standardized rate of world，cumulative rate(0~74 years old) by urban and rural areas and age groups of female breast cancer.Results:In 2017，there were 1 450 female breast cancer cases and 288 deaths in the tumor registration area of Heilongjiang Province.The incidence of breast cancer was 60.27/100 000，the age-standardized rate of China was 36.65/100 000，the mortality of breast cancer was 11.97/100 000，and the age-standardized rate of China was 6.61/100 000.The incidence(mortality) of breast cancer among women in urban areas is higher than that in rural areas.The incidence of breast cancer in females increased significantly after the age of 40，and the incidence reached a peak in the 60~64 years old age group(122.97/100 000).There were no deaths before the age of 25，and the mortality rate increased with age until the age of 65，followed by a slight decline until the mortality rate peaked in the 85+ age group(50.64/100 000).From 2013 to 2017，the morbidity(mortality) rate was the highest in the 45~64 years old age group.Conclusion:Female breast cancer is one of the most common malignant tumors in Heilongjiang Province，and women of the right age in rural areas are the key population for cancer prevention and treatment.

References:

［1］SUNG H，FERLAY J，SIEGEL RL，et al.Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2021，71(3):209-249.
［2］张雅聪，吕章艳，宋方方，等.全球及我国乳腺癌发病和死亡变化趋势［J］.肿瘤综合治疗电子杂志，2021，7(2):14-20. ZHANG YC，LYU ZY，SONG FF，et al.Trends of incidence and mortality of breast cancer worldwide and in China［J］.Journal of Multidisciplinary Cancer Management(Electronic Version)，2021，7(2):14-20.
［3］刘威，王黎君，齐金蕾，等.1990-2017年中国女性乳腺癌疾病负担分析［J］.中华流行病学杂志，2021，42(7):1225-1230. LIU W，WANG LJ，QI JL，et al.Disease burden of breast cancer in women in China，1990-2017［J］.Chinese Journal of Epidemiology，2021，42(7):1225-1230.
［4］ZHANG SW，SUN KX，ZHENG RS，et al.Cancer incidence and mortality in China，2015［J］.JNCC，2020，1(1):2-11.
［5］于洗河，张景茹，降海蕊，等.中国女性1990-2019年宫颈癌和乳腺癌疾病负担分析［J］.中国公共卫生，2022，38(5):534-538. YU XH，ZHANG JR，JIANG HR，et al.Disease burden of cervical cancer and breast cancer in Chinese women in 1990 and 2019［J］.Chinese Journal of Public Health，2022，38(5):534-538.
［6］郑文龙，沈成凤，张辉，等.天津市2008-2016年女性乳腺癌发病及死亡趋势分析［J］.中国肿瘤，2020，29(8):596-601. ZHENG WL，SHEN CF，ZHANG H，et al.An analysis on the variation trends of female breast cancer's incidence and mortality from 2008 to 2016 in Tianjin［J］.China Cancer，2020，29(8):596-601.
［7］朱云芳，文洪梅，秦明芳，等.2011-2016年云南省肿瘤登记地区女性乳腺癌发病和死亡情况分析［J］.实用肿瘤学杂志，2021，35(1):18-22. ZHU YF，WEN HM，QIN MF，et al.Analysis on the incidence and death of female breast cancer in Yunnan cancer registration areas from 2011 to 2016［J］.Practical Oncology Journal，2021，35(1):18-22.
［8］陈文婕，董玮琪，乔丽颖，等.2015年内蒙古自治区女性乳腺癌发病与死亡情况及2010-2015年趋势分析［J］.中国肿瘤，2020，29(10):736-743. CHEN WJ，DONG WQ，QIAO LY，et al.Incidence and mortality of female breast cancer in Inner Mongolia in 2015 and its trend from 2010 to 2015［J］.China Cancer，2020，29(10):736-743.
［9］秦朝，李江，郑亚迪，等.中国城市乳腺癌高危人群筛查依从性及其相关因素分析［J］.实用肿瘤学杂志，2021，35(4):291-296. QIN C，LI J，ZHENG YD，et al.Analysis of screening compliance and related factors in high-risk populations of breast cancer in Chinese cities［J］.Practical Oncology Journal，2021，35(4):291-296.
［10］连臻强，王颀.中国农村妇女乳腺癌筛查的实践与经验［J］.中国普外基础与临床杂志，2020，27(11):18-21. LIAN ZQ，WANG S.The practice and experience of breast cancer screening in rural China［J］.Chinese Journal of Bases and Clinics in General Surgery，2020，27(11):18-21.
［11］李杰，张雪，李道娟，等.2011-2015年河北省肿瘤登记地区女性乳腺癌发病死亡分析［J］.肿瘤预防与治疗，2019，32(11):962-968. LI J，ZHANG X，LI DJ，et al.Analysis of incidence and mortality of breast cancer in cancer registration areas of Hebei Province from 2011 to 2015［J］.Journal of Cancer Control and Treatment，2019，32(11):962-968.
［12］ENGMANN NJ，GOLMAKANI MK，MIGLIORETTI DL，et al.Population-attributable risk proportion of clinical risk factors for breast cancer［J］.JAMA Oncol，2017，3(9)：1228-1236.
［13］THAKUR P，SEAM RK，GUPTA MK，et al.Breast cancer risk factor evaluation in a Western Himalayan state：A case-control study and comparison with the Western World［J］.South Asian J Cancer，2017，6(3)：106-109.
［14］林丹丽，陈机琼，冯慧艳，等.血清性激素水平，体重指数与绝经后女性乳腺癌疾病进展的相关性分析［J］.吉林医学，2020，41(1):38-40. LIN DL，CHEN JQ，FENG HY，et al.Correlation between serum sex hormone levels，body mass index and progression of breast cancer in postmenopausal women［J］.Jilin Medical Journal，2020，41(1):38-40.
［15］RAJESH S.Examination of incidence，mortality and disability-adjusted life years and risk factors of breast cancer in 49 Asian countries，1990-2019：estimates from Global Burden of Disease Study 2019［J］.JJCO，2021，5(51):826-835.
［16］孙惠昕，张茂祥，王婉莹，等.2017年黑龙江省肿瘤登记地区恶性肿瘤流行情况分析［J］.实用肿瘤杂志，2021，36(3):222-227. SUN HX，ZHANG MX，WANG WY，et al.Malignant tumor epidemiology in registration areas of Heilongjiang Province in 2017［J］.Journal of Practical Oncology，2021，36(3):222-227.

Memo

Memo:
消化道早癌医师共同成长计划（编号：GTCZ-2021-HLJ-23-0002）;黑龙江省自然科学基金优秀青年项目（编号：YQ2021H021）
Last Update: 2023-03-30